SCHEMBL5468482

SCHEMBL5468482

O=C(Nc1cccc(C(F)(F)F)c1)Nc1ccc(-c2cccnc2)cc1-c1nnn[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDH2 P48735 2/20 0.53
KDR P35968 9/20 0.52
RIPK1 Q13546 1/20 0.49
TRPV1 Q8NER1 1/20 0.49
EGFR P00533 3/20 0.48
FGFR1 P11362 2/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
TSHR P16473 1/20 0.47
ERN1 O75460 1/20 0.46
FYN P06241 3/20 0.46
CSF1R P07333 3/20 0.46
KIT P10721 3/20 0.46
FLT1 P17948 3/20 0.46
FLT3 P36888 3/20 0.46
LCK P06239 2/20 0.46
LYN P07948 2/20 0.46
FLT4 P35916 2/20 0.46
BLK P51451 2/20 0.46
ABL1 P00519 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3577053 0.89 KDR (0.51) KDREGFRMEN1KMT2AFYN
SCHEMBL3570022 0.87 KDR (0.45) KDRTRPV1EGFRMEN1KMT2A
SCHEMBL3581371 0.86 NTRK1 (0.53) KDRTRPV1EGFRMEN1KMT2A
SCHEMBL5474091 0.86 GRIK1 (0.48) KDREGFRMEN1KMT2AFYN
SCHEMBL5471923 0.86 GRIK1 (0.51) KDRTRPV1EGFRMEN1KMT2A
SCHEMBL5468488 0.85 KDR (0.49) KDRRIPK1EGFRMEN1KMT2A
SCHEMBL5476689 0.85 KDR (0.46) KDRRIPK1EGFRMEN1KMT2A
SCHEMBL5474009 0.84 TRPV1 (0.56) KDRTRPV1EGFRMEN1KMT2A
SCHEMBL5468806 0.84 MEN1 (0.48) KDRRIPK1EGFRMEN1KMT2A
SCHEMBL5471950 0.84 IDH2 (0.53) IDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293553-A1 Diphenylurea Derivatives Useful As Potassium Channel Activators NEUROSEARCH A/S (DK) 2007-12-20 US claimed
US-20070293553-A1 Diphenylurea Derivatives Useful As Potassium Channel Activators NEUROSEARCH A/S (DK) 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293553-A1 Diphenylurea Derivatives Useful As Potassium Channel Activators KCNJ2, KCNH2, KCNH3 IDH2 1264/4885KDR 1142/4885RIPK1 3590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.